| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8667969 | Journal of Cardiology | 2018 | 8 Pages |
Abstract
Our study shows that the recommended dose of prasugrel had significantly higher in-hospital bleeding complications without reducing ischemic events compared with clopidogrel. However, further large-scale, long-term, randomized clinical trials are required to accurately assess the efficacy and safety of prasgurel and to find out the optimal dose for Korean AMI patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Keun-Ho MD, Myung Ho MD, Hyun Kuk MD, Tae Hoon MD, Ki Bae MD, Dong Joo MD, Dong-Joo MD, Hyo-Soo MD, Hyeon Cheol MD, In Whan MD, Kyung Kuk MD, Shung Chull MD, Kwon-Bae MD, Young Jo MD, Kwang Soo MD, Seok Kyu MD, Jei Keon MD,